Erst- und Seniorautorenschaften
Tumor budding correlates with tumor invasiveness and predicts worse survival in pT1 non-muscle-invasive bladder cancer
Sci Rep. 2021 Sep 9;11(1):17981. Eckstein M, Kimmel C, Bruendl J, Weber F, Denzinger S, Gierth M, Burger M, Hartmann A, Otto W, Breyer J.
Oncological Long-term Outcome After Whole-gland High-intensity Focused Ultrasound for Prostate Cancer-21-yr Follow-up
Eur Urol Focus. 2021 Jan 19:S2405-4569(20)30318-7. Bründl J, Osberghaus V, Zeman F, Breyer J, Ganzer R, Blana A, Gierth M, Denzinger S, Burger M, Rosenhammer B.
Nonmuscle invasive bladder cancer: Challenge for practitioner and patient!
Urologe A. 2021 Nov;60(11):1389-1390. Noldus J, Grimm MO, Burger M.
Urologic cancer care during the first wave of the COVID-19 pandemic: Role of federal cancer registration in Germany
Urologe A. 2021 Mar;60(3):291-300. Bolenz C, Vogel T, Morakis P, Mayr R, Marx M, Burger M.
The HELENA study: Hexvix()-TURB vs. white-light TURB followed by intravesical adjuvant chemotherapy-a prospective randomized controlled open-label multicenter non-inferiority study
World J Urol. 2021 Oct;39(10):3799-3805. Gierth M, Breyer J, Zeman F, Fritsche HM, Cordes J, Karl A, Zaak D, Stenzl A, von Schmeling IK, Sommerhuber A, Zierer T, Burger M, Mayr R.
Randomized Crossover-Controlled Evaluation of Simultaneous Bilateral Transcutaneous Electrostimulation of the Posterior Tibial Nerve During Urodynamic Studies in Patients With Lower Urinary Tract Symptoms
Int Neurourol J. 2021 Jan 27. Girtner F, Fritsche HM, Zeman F, Huber T, Haider M, Pickl C, Burger M, Mayr R.
Epidemiology and therapy of symptomatic lymphoceles after robot-assisted radical prostatectomy (RARP)
Transl Androl Urol. 2021 Feb;10(2):821-829. Goßler C, Hillinger J, Burger M, Bründl J, Denzinger S, Gierth M, Breyer J
High BMI, Aggressive Tumours and Long Console Time Are Independent Predictive Factors for Symptomatic Lymphocele Formation after Robot-Assisted Radical Prostatectomy and Pelvic Lymph Node Dissection
Urol Int. 2021;105(5-6):453-459. Goßler C, May M, Breyer J, Stojanoski G, Weikert S, Lenart S, Ponholzer A, Dreissig C, Burger M, Gilfrich C, Bründl J, Rosenhammer B.
Early Revision after Artificial Urinary Sphincter Implantation Does Not Impair the Long-Term Treatment Success
Urol Int. 2021 Jul 21:1-8. Sayedahmed K, Rosenhammer B, Burger M, Goßler C
Systemic treatment of bladder cancer
Urologe A. 2021 Sep;60(9):1167-1174. Haas M, Burger M, Schnabel MJ
24/m with macrohematuria and dysuria: Preparation for the specialist examination: part 31
Urologe A. 2021 Dec 16; Haider M, Girtner F, Burger M, Bründl J
Juvenile granulosa cell tumor-Testicular tumor of the very young: Report of three cases and contemporary recommendations
Urologe A. 2021 Feb;60(2):222-225. Haider M, Comploj E, Hofmann A, Rösch WH.
Expression of Low Affinity Nerve Growth Factor Receptor p75 in Classic Bladder Exstrophy
Front Pediatr. 2021 Feb 22;9:634343. Promm M, Otto W, Weber F, Götz S, Burger M, Müller K, Rubenwolf P, Neuhuber W, Roesch WH.
Evaluation of Undescended Testes in Newborns: It Is Really Simple, Just Not Easy
Urol Int. 2021;105(11-12):1034-1038. Promm M, Dittrich A, Brandstetter S, Fill-Malfertheiner S, Melter M, Seelbach-Göbel B, Apfelbacher C, Kabesch M, Rösch WH.
Congenital Heart Defects in Patients with Classic Bladder Exstrophy: A Hitherto Neglected Association?
Eur J Pediatr Surg. 2021 Mar 7. Promm M, Gerling S, Schepp CP, Rösch WH.
Persistent urothelial differentiation changes in the reconstructed exstrophic bladder: Congenital or acquired dysfunction of the epithelial barrier?
J Pediatr Urol. 2021 Oct;17(5):632.e1-632.e7. Rubenwolf P, Eder F, Götz S, Promm M, Rösch WH.
Persistent urothelial differentiation changes in the reconstructed exstrophic bladder: Congenital or acquired dysfunction of the epithelial barrier?
J Pediatr Urol. 2021 Dec;17(6):869..Rubenwolf P, Rösch WH.
A fall for the urologist
Urologe A. 2021 Dec;60(12):1591-1593. Schnabel MJ, Schmitz P
Miniaturized percutaneous Nephrolithotomy without antibiotic prophylaxis: a single institution experience
Int Urol Nephrol. 2021 Aug;53(8):1551-1556. Schnabel MJ, Rosenhammer B, Steckermeier M, Fritsche HM, Burger M, Spachmann PJ.
Impact of Male Patient Information on Quality of Urine Examination (PIQUE Study)
Urol Int. 2021 Aug 26:1-5.Spachmann PJ, Rupp C, Fritsche HM, Denzinger S, Burger M, Breyer J, Otto W, Schnabel MJ
Geriatric Patients and Symptomatic Urinary Tract Infections: Analysis of Bacterial Range and Resistance Rates at a 3rd Level of Care Hospital in Germany
Urol Int. 2021 Jun 25:1-6. Manseck AS, Otto W, Schnabel M, Denzinger S, Burger M, Spachmann PJ.
Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study
Eur Urol Oncol. 2021 Apr;4(2):182-191. van Rhijn BWG, Hentschel AE, Bründl J, Compérat EM, Hernández V, Čapoun O, Bruins HM, Cohen D, Rouprêt M, Shariat SF, Mostafid AH, Zigeuner R, Dominguez-Escrig JL, Burger M, Soukup V, Gontero P, Palou J, van der Kwast TH, Babjuk M, Sylvester RJ;
European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel
Eur Urol. 2021 Apr;79(4):480-488. Sylvester RJ, Rodríguez O, Hernández V, Turturica D, Bauerová L, Bruins HM, Bründl J, van der Kwast TH, Brisuda A, Rubio-Briones J, Seles M, Hentschel AE, Kusuma VRM, Huebner N, Cotte J, Mertens LS, Volanis D, Cussenot O, Subiela Henríquez JD, de la Peña E, Pisano F, Pešl M, van der Heijden AG, Herdegen S, Zlotta AR, Hacek J, Calatrava A, Mannweiler S, Bosschieter J, Ashabere D, Haitel A, Côté JF, El Sheikh S, Lunelli L, Algaba F, Alemany I, Soria F, Runneboom W, Breyer J, Nieuwenhuijzen JA, Llorente C, Molinaro L, Hulsbergen-van de Kaa CA, Evert M, Kiemeney LALM, N'Dow J, Plass K, Čapoun O, Soukup V, Dominguez-Escrig JL, Cohen D, Palou J, Gontero P, Burger M, Zigeuner R, Mostafid AH, Shariat SF, Rouprêt M, Compérat EM, Babjuk M, van Rhijn BWG.
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival
World J Urol. 2021 Dec;39(12):4363-4371. Claps F, van de Kamp MW, Mayr R, Bostrom PJ, Boormans JL, Eckstein M, Mertens LS, Boevé ER, Neuzillet Y, Burger M, Pouessel D, Trombetta C, Wullich B, van der Kwast TH, Hartmann A, Allory Y, Lotan Y, Shariat SF, Zuiverloon TCM, Mir MC, van Rhijn BWG.
Two Patients with Urachal Cancer with Multifocal Adenocarcinoma Recurrences in the Urothelium of the Prostatic and Penile Urethra
Eur Urol Open Sci. 2021 Sep 24;33:56-60. Stokkel LE, van Montfoort ML, van Boven HH, Mertens LS, van Rhijn BWG
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
Urol Oncol. 2021 Dec 11:S1078-1439(21)00475-0. Mertens LS, Claps F, Mayr R, Bostrom PJ, Shariat SF, Zwarthoff EC, Boormans JL, Abas C, van Leenders GJLH, Götz S, Hippe K, Bertz S, Neuzillet Y, Sanders J, Broeks A, Peters D, van der Heijden MS, Jewett MAS, Stöhr R, Zlotta AR, Eckstein M, Soorojebally Y, van der Schoot DKE, Wullich B, Burger M, Otto W, Radvanyi F, Sirab N, Pouessel D, van der Kwast TH, Hartmann A, Lotan Y, Allory Y, Zuiverloon TCM, van Rhijn BWG.
Co-Autorenschaften
Quality assessment of radical cystectomy-opportunities, risks, challenges
Urologe A. 2021 Feb;60(2):151-16. Roghmann F, Breyer J, Kriegmair M, Wezel F, Burger M, Noldus J, Bolenz C;
Bladder Tumor Subtype Commitment Occurs in Carcinoma In Situ Driven by Key Signaling Pathways Including ECM Remodeling
Cancer Res. 2021 Mar 15;81(6):1552-1566. Wullweber A, Strick R, Lange F, Sikic D, Taubert H, Wach S, Wullich B, Bertz S, Weyerer V, Stoehr R, Breyer J, Burger M, Hartmann A, Strissel PL, Eckstein M.
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer
Life (Basel). 2021 Jun 30;11(7):642. Sikic D, Taubert H, Wirtz RM, Breyer J, Eckstein M, Weyerer V, Kubon J, Erben P, Bolenz C, Burger M, Hartmann A, Wullich B, Wach S, Keck B.
Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy
Urology. 2021 Nov;157:93-10. Tully KH, Jütte H, Wirtz RM, Jarczyk J, Santiago-Walker A, Zengerling F, Breyer J, Sikic D, Kriegmair MC, von Hardenberg J, Wullich B, Taubert H, Weyerer V, Stoehr R, Bolenz C, Burger M, Porubsky S, Hartmann A, Roghmann F, Erben P, Eckstein M.
The Prognostic Value of FGFR3 Expression in Patients with T1 Non-Muscle Invasive Bladder Cancer
Cancer Manag Res. 2021 Aug 20;13:6567-6578.Sikic D, Taubert H, Breyer J, Eckstein M, Weyerer V, Keck B, Kubon J, Otto W, Worst TS, Kriegmair MC, Erben P, Hartmann A, Wullich B, Wirtz RM, Wach S.
Validation of a German translation of the CARE questionnaire and its implementation as electronic PROM to assess patient-reported postoperative convalescence and recovery after major urological surgery
World J Urol. 2021 Oct;39(10):3979-3991. Wessels F, Lenhart M, Neuberger M, Mühlbauer J, Huber J, Breyer J, Nuhn P, Michel MS, Koenig J, Kriegmair MC.
High expression of ERBB2 is an independent risk factor for reduced recurrence-free survival in patients with stage T1 non-muscle-invasive bladder cancer
Urol Oncol. 2021 Jul 27:S1078-1439(21)00297-0. Sikic D, Eckstein M, Weyerer V, Kubon J, Breyer J, Roghmann F, Kunath F, Keck B, Erben P, Hartmann A, Wirtz RM, Wullich B, Taubert H, Wach S.
Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients
Cancers (Basel). 2021 May 12;13(10):2327. Weyerer V, Strissel PL, Strick R, Sikic D, Geppert CI, Bertz S, Lange F, Taubert H, Wach S, Breyer J, Bolenz C, Erben P, Schmitz-Draeger BJ, Wullich B, Hartmann A, Eckstein M.
Active surveillance inclusion criteria under scrutiny in magnetic resonance imaging-guided prostate biopsy: a multicenter cohort study
Prostate Cancer Prostatic Dis. 2021 Dec 17. Kornienko K, Siegel F, Borkowetz A, Hoffmann MA, Drerup M, Lieb V, Bruendl J, Höfner T, Cash H, von Hardenberg J, Westhoff N
Triggers and oncologic outcome of salvage radical prostatectomy, salvage radiotherapy and active surveillance after focal therapy of prostate cancer
World J Urol. 2021 Oct;39(10):3747-3754. von Hardenberg J, Cash H, Koch D, Borkowetz A, Bruendl J, Leyh-Bannurah SR, Kuru TH, Kowalewski KF, Schindele D, Mala KS, Westhoff N, Blana A, Schostak M;
Does the Identification of a Minimum Number of Cases Correlate With Better Adherence to International Guidelines Regarding the Treatment of Penile Cancer? Survey Results of the European PROspective Penile Cancer Study (E-PROPS)
Front Oncol. 2021 Nov 29;11:759362. Lebentrau S, Wakileh GA, Schostak M, Schmid HP, Suarez-Ibarrola R, Merseburger AS, Hutterer GC, Necknig UH, Rink M, Bögemann M, Kluth LA, Pycha A, Burger M, Brookman-May SD, Bründl J, May M.
Risk of penile tumor development in Caucasian individuals is independent of the coding variant rs7208422 in the TMC8 (EVER2) gene
Mol Clin Oncol. 2021 Dec;15(6):267. Stoehr R, Wendler O, Giedl J, Gaisa NT, Richter G, Campean V, Burger M, Wullich B, Bertz S, Hartmann A.
Clinical Importance of a Peritoneal Interposition Flap to Prevent Symptomatic Lymphoceles after Robot-Assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-Analysis
Urol Int. 2021 Feb 10:1-7. Deutsch S, Hadaschik B, Lebentrau S, Ubrig B, Burger M, May M.
Early cystectomy-patient selection and technique
Urologe A. 2021 Nov;60(11):1424-1431. Roghmann F, Mayr R, Tully K, Engelmann S, Burger M, Noldus J.
Dose estimates of occupational radiation exposure during radioguided surgery of Tc-99m-PSMA-labeled lymph nodes in recurrent prostate cancer
Nuklearmedizin. 2021 Dec;60(6):425-433.Schmidt D, Grosse J, Mayr R, Burger M, Hellwig D.
Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals
World J Urol. 2021 Nov 30:1–10. Struck JP, Schnoor M, Schulze A, Hupe MC, Ozimek T, Oppolzer IA, Schnabel MJ, Burger M, Darr C, Gruenwald V, Hadaschik B, Weinke M, Kuebler H, Klockenbusch JC, Grabbert MT, Gratzke C, Kramer MW, Katalinic A, Merseburger AS.
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)
Eur Urol. 2022 Jan;81(1):75-94. Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Dominguez Escrig JL, Gontero P, Liedberg F, Masson-Lecomte A, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Seisen T, Soukup V, Sylvester RJ.
Y-chromosome loss is frequent in male renal tumors
Ann Transl Med. 2021 Feb;9(3):209. Büscheck F, Fraune C, Garmestani S, Simon R, Kluth M, Hube-Magg C, Ketterer K, Eichelberg C, Höflmayer D, Jacobsen F, Wittmer C, Wilczak W, Sauter G, Fisch M, Eichenauer T, Rink M.
The Effect of Low-intensity Shockwave Therapy on Non-neurogenic Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Preclinical and Clinical Studies
Eur Urol Focus. 2021 May 10:S2405-4569(21)00127-9. Sokolakis I, Pyrgidis N, Neisius A, Gierth M, Knoll T, Rassweiler J, Hatzichristodoulou G;
Kynurenine induces T cell fat catabolism and has limited suppressive effects in vivo
EBioMedicine. 2021 Dec;74:103734. Siska PJ, Jiao J, Matos C, Singer K, Berger RS, Dettmer K, Oefner PJ, Cully MD, Wang Z, QuinnIII WJ, Oliff KN, Wilkins BJ, Christensen LM, Wang L, Hancock WW, Baur JA, Levine MH, Ugele I, Mayr R, Renner K, Zhou L, Kreutz M, Beier UH.
Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic in Urology
Urol Int. 2021;105(3-4):199-205. Borgmann H, Struck JP, Mattigk A, Wenzel M, Pilatz A, Kranz J, Weiten R, von Landenberg N, Spachmann PJ, Aksoy C, Haferkamp A, Boehm K.
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
Int J Cancer. 2021 Feb 15;148(4):981-987..van Doeveren T, Nakauma-Gonzalez JA, Mason AS, van Leenders GJLH, Zuiverloon TCM, Zwarthoff EC, Meijssen IC, van der Made AC, van der Heijden AG, Hendricksen K, van Rhijn BWG, Voskuilen CS, van Riet J, Dinjens WNM, Dubbink HJ, van de Werken HJG, Boormans JL.
Hospital volume is associated with postoperative mortality after radical cystectomy for treatment of bladder cancer
BJU Int. 2021 Oct;128(4):511-518. Richters A, Ripping TM, Kiemeney LA, Leliveld AM, van Rhijn BWG, Oddens JR, van Moorselaar RJA, Goossens-Laan CA, Meijer RP, Boormans JL;
The Diagnostic Value of FDG-PET/CT for Urachal Cancer
Clin Genitourin Cancer. 2021 Oct;19(5):373-380. Stokkel LE, Stokkel MPM, Donswijk ML, Lahaye MJ, Bekers EM, van Rhijn BWG, Mertens LS.
Staging (18)F fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Changes Treatment Recommendation in Invasive Bladder Cancer
Eur Urol Oncol. 2021 Feb 11:S2588-9311(21)00029-8. Voskuilen CS, van Gennep EJ, Einerhand SMH, Vegt E, Donswijk ML, Bruining A, van der Poel HG, Horenblas S, Hendricksen K, van Rhijn BWG, Mertens LS.
Kontakt
Terminvereinbarung und
Befundanforderungen:
E-Mail uro-ambulanz@csj.de
Telefon 0941 782-3511
Fax 0941 782-3545
Sekretariat:
E-Mail urologie@csj.de
Telefon 0941 782-3510
Fax 0941 782-3515
